Condition: Cystic Fibrosis Lung · Sponsor: 4D Molecular Therapeutics
This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis.
This description comes directly from the study's public registry record.
4DMT Patient Advocacy · (888) 748-8881 · clinicaltrials@4DMT.com
Always discuss trial participation with your own doctor first.
| University of Alabama Child Health Research Unit | Birmingham, Alabama, United States | Recruiting |
| The University of Arizona | Tucson, Arizona, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| National Jewish Health | Denver, Colorado, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| University of Miami Hospital | Miami, Florida, United States | Recruiting |
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Completed |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05248230